These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6746028)

  • 21. [In vivo activity of cytotoxic lymphocytes directed against the product of gene H-2Kb and its mutant alleles].
    Nikonenko BV; Pospelov LE
    Biull Eksp Biol Med; 1981 Apr; 91(4):479-80. PubMed ID: 7020792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
    Pircher H; Hämmerling G; Hengartner H
    Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region.
    Forman J
    J Immunol; 1979 Dec; 123(6):2451-5. PubMed ID: 387870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell determinant mapping between K and I-A with I-region properties.
    Hayes CE; Klyczek KK; Maier JM
    Exp Clin Immunogenet; 1984; 1(1):43-55. PubMed ID: 6101096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of D-locus alleles in mouse B10.W lines.
    Tewarson S; Figueroa F; Klein J
    Immunogenetics; 1982; 16(3):273-8. PubMed ID: 7141493
    [No Abstract]   [Full Text] [Related]  

  • 26. Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 region.
    Kastner DL; Rich RR; Shen FW
    J Immunol; 1979 Sep; 123(3):1232-8. PubMed ID: 89166
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of an H-2Kd mutant strain: C.B6-H-2dm4.
    Morgan G; Dellos H; McKenzie IF; Melvold RW
    Immunogenetics; 1981 Mar; 12(5-6):555-60. PubMed ID: 6452410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytolytic T lymphocyte precursors reactive against mutant Kb alloantigens are as frequent as those reactive against a whole foreign haplotype.
    Widmer MB; MacDonald HR
    J Immunol; 1980 Jan; 124(1):48-51. PubMed ID: 6153106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic control of allograft tolerance: importance of H-2 subregions.
    Click RE; Cahill G; Condie RM; Azar MM; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):582-5. PubMed ID: 7022894
    [No Abstract]   [Full Text] [Related]  

  • 31. Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies.
    Hämmerling GJ; Hämmerling U; Flaherty L
    J Exp Med; 1979 Jul; 150(1):108-16. PubMed ID: 312902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. 1986.
    Kärre K; Ljunggren HG; Piontek G; Kiessling R
    J Immunol; 2005 Jun; 174(11):6566-9. PubMed ID: 15905492
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants.
    Isakov N; Bach FH
    Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T lymphocyte responses to minor H-43 alloantigens in H-43a and H-43b mice. Both anti-H-43b and anti-H-43a CTL activities are generated exclusively in the context of the same H-2Kb restriction element.
    Ishikawa H; Kusakabe A; Hayakawa J; Hino T
    J Immunol; 1988 Nov; 141(9):2918-23. PubMed ID: 3139769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manufacture of a functional cDNA for the H-2Db molecule using a retroviral shuttle vector.
    Joly E; Oldstone MB
    Immunogenetics; 1991; 34(1):62-5. PubMed ID: 1713192
    [No Abstract]   [Full Text] [Related]  

  • 36. [Induction of T-cells--producers of macrophage migration inhibitory factors by mutant H-2 antigens in vivo].
    Kharkevich DD; Suslov AP; Blandova ZK
    Biull Eksp Biol Med; 1984 Apr; 97(4):443-5. PubMed ID: 6372888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H-2K region-controlled products of the murine major histocompatibility complex differ in their immunogenic capacity when expressed on different tissues.
    Isakov N; Feldman M; Segal S
    Transplantation; 1981 Oct; 32(4):291-5. PubMed ID: 6173938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity and regulation of cytotoxic T-lymphocyte responses analyzed with H-2 mutants.
    Melief CJ; Stukart MJ; de Waal LP; Kast WM; Melvold RW
    Transplant Proc; 1983 Dec; 15(4):2086-9. PubMed ID: 6324427
    [No Abstract]   [Full Text] [Related]  

  • 40. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
    Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
    J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.